Ebpay生命医药出版社

Ebpay生命

100763

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

拮抗剂方案中触发日孕酮水平与基础孕酮水平比值与体外受精 - 胚胎移植结局之间的关联

 

Authors Xu MY, Wang YT, Liu YF 

Received 29 November 2024

Accepted for publication 20 February 2025

Published 8 March 2025 Volume 2025:17 Pages 663—671

DOI http://doi.org/10.2147/IJWH.S506574

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Matteo Frigerio

Miao-Yi Xu, Yu-Ting Wang, Yao-Fang Liu

Department of Reproductive Technology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, 646000, People’s Republic of China

Correspondence: Yao-Fang Liu, Department of Reproductive Technology, The Affiliated Hospital of Southwest Medical University, No. 25 of Taiping Street, Luzhou, Sichuan Province, 646000, People’s Republic of China, Tel +860830-3165649, Email liuyf_as11@163.com

Objective: To investigate the relationship between the progesterone level on trigger day (Ptrigger) to basal progesterone (bP) ratio and the outcomes of in vitro fertilization-embryo transfer (IVF-ET).
Methods: A retrospective analysis was conducted on women who received an antagonist protocol, with a Ptrigger less than 1.5 ng/mL and who underwent fresh embryo transfer. Based on the Ptrigger/bP ratio, participants were categorized into four groups: group A (Ptrigger/bP < 1, n = 284), group B (Ptrigger/bP ≥ 1 and < 2, n = 363), group C (Ptrigger/bP ≥ 2 and < 3, n = 165), and group D (Ptrigger/bP ≥ 3, n = 118). Recombinant follicle-stimulating hormone was used to stimulate ovulation. Receiver operating characteristic curve analysis was used to analyze the accuracy of the Ptrigger/bP ratio in predicting clinical pregnancy following fresh embryo transfer.
Results: A decreasing trend in bP levels was observed across groups (A > B > C > D), while Ptrigger levels showed an increasing trend (A < B < C < D). Groups A and B included significantly younger women and required lower doses of gonadotropin (Gn) compared to Groups C and D. The embryo implantation and clinical pregnancy rates in Group A were 34.93% and 49.30%, respectively, significantly higher than those in Group D (23.19% and 33.90%, respectively). After propensity score matching for age, the differences in implantation and clinical pregnancy rates were not statistically significant between Group A and D. The Ptrigger/bP ratio had limited accuracy in predicting clinical pregnancy, with an area under the curve of 0.538 (95% CI [confidence interval]: 0.501– 0.575, P = 0.044).
Conclusion: A Ptrigger/bP ratio of less than 1 was associated with relatively favorable pregnancy outcomes in women undergoing IVF-ET with an antagonist protocol for ovulation induction.

Keywords: antagonist protocol, basal progesterone, bP, IVF-ET outcome, in vitro fertilization-embryo transfer, IVF-ET, progesterone level on trigger day, Ptrigger

Download Article[PDF]